Some shareholders of Novoprotein plan to reduce their holdings by no more than 1.04%

According to the Zhitong Finance APP, Novoprotein (688137.SH) announced that its shareholders Nanjing Jinli Venture Capital Partnership (Limited Partnership) (referred to as "Nanjing Jinli") and Suzhou Jinling Venture Capital Partnership (Limited Partnership) (referred to as "Suzhou Jinling") plan to collectively reduce their holdings in the company by no more than 728,600 shares, accounting for 1.04% of the company's total share capital